Terms: = Leukemia AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Treatment
12 results:
1. Cost in the United States of FDA-approved small molecule protein kinase inhibitors used in the treatment of neoplastic and non-neoplastic diseases.
Roskoski R
Pharmacol Res; 2024 Jan; 199():107036. PubMed ID: 38096958
[TBL] [Abstract] [Full Text] [Related]
2. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-fgfr2 signaling.
Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
[TBL] [Abstract] [Full Text] [Related]
3. Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-fgfr2 rearrangement.
Carll T; Patel A; Derman B; Hyjek E; Lager A; Wanjari P; Segal J; Odenike O; Fidai S; Arber D
Blood Adv; 2020 Oct; 4(19):4924-4928. PubMed ID: 33049052
[TBL] [Abstract] [Full Text] [Related]
4. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Röllig C; Kramer M; Schliemann C; Mikesch JH; Steffen B; Krämer A; Noppeney R; Schäfer-Eckart K; Krause SW; Hänel M; Herbst R; Kunzmann V; Einsele H; Jost E; Brümmendorf TH; Scholl S; Hochhaus A; Neubauer A; Sohlbach K; Fransecky L; Kaufmann M; Niemann D; Schaich M; Frickhofen N; Kiani A; Heits F; Krümpelmann U; Kaiser U; Kullmer J; Wass M; Stölzel F; von Bonin M; Middeke JM; Thiede C; Schetelig J; Berdel WE; Ehninger G; Baldus CD; Müller-Tidow C; Platzbecker U; Serve H; Bornhäuser M
Blood; 2020 Aug; 136(7):823-830. PubMed ID: 32496541
[TBL] [Abstract] [Full Text] [Related]
5. Multipotent Mesenchymal Stromal Cells in Patients with Chronic Myeloid leukemia before Discontinuation of Tyrosine Kinase Inhibitors.
Petinati NA; Petrova AN; Chelysheva EY; Shukhov OA; Bykova AV; Nemchenko IS; Sats NV; Turkina AG; Drize NI
Bull Exp Biol Med; 2019 Aug; 167(4):580-583. PubMed ID: 31502137
[TBL] [Abstract] [Full Text] [Related]
6. Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment.
Shipounova IN; Petinati NA; Bigildeev AE; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
Leuk Lymphoma; 2019 Aug; 60(8):2042-2049. PubMed ID: 30668205
[TBL] [Abstract] [Full Text] [Related]
7. Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases.
Hilberg F; Tontsch-Grunt U; Baum A; Le AT; Doebele RC; Lieb S; Gianni D; Voss T; Garin-Chesa P; Haslinger C; Kraut N
J Pharmacol Exp Ther; 2018 Mar; 364(3):494-503. PubMed ID: 29263244
[TBL] [Abstract] [Full Text] [Related]
8. Estimation of the prevalence and direct medical costs of chronic myeloid leukemia in the I.R. of Iran in the era of tyrosine kinase inhibitors.
Daroudi R; Mirzania M; Nikravanfard N; Sadighi S; Sedighi Z; Zendehdel K
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e416-e422. PubMed ID: 26990676
[TBL] [Abstract] [Full Text] [Related]
9. Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models.
Zhang H; Hylander BL; LeVea C; Repasky EA; Straubinger RM; Adjei AA; Ma WW
Br J Cancer; 2014 Jan; 110(2):320-9. PubMed ID: 24327018
[TBL] [Abstract] [Full Text] [Related]
10. [Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia].
Motyčková M; Smolej L; Andrýs C; Rezáčová V; Reháček V; Simkovič M; Belada D; Zák P
Vnitr Lek; 2013 Sep; 59(9):782-93. PubMed ID: 24073950
[TBL] [Abstract] [Full Text] [Related]
11. Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation.
Huebner G; Karthaus M; Pethig K; Freund M; Ganser A
Transplantation; 2000 Aug; 70(4):688-90. PubMed ID: 10972231
[TBL] [Abstract] [Full Text] [Related]
12. k-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors.
Hattori Y; Odagiri H; Katoh O; Sakamoto H; Morita T; Shimotohno K; Tobinai K; Sugimura T; Terada M
Cancer Res; 1992 Jun; 52(12):3367-71. PubMed ID: 1317750
[TBL] [Abstract] [Full Text] [Related]
